Licensed Medical Professionals Administered by licensed medical professionals in a clinical IV therapy setting
This is a primary research observation, not an approved indication
Recalls & Warnings December 01, 2015 Multivitamins Recalled Due to Risk of Vitamin D Toxicity On November 25, 2015, Glades Drugs, a compounding pharmacy in Pahokee, Florida, issued a recall of its compounded multivitamin capsules because they contain high amounts of vitamin D3 (exact amount was not reported)
Based on data from the Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023, the timeline for seeing meaningful results with retatrutide generally follows a predictable pattern, though individual responses vary considerably depending on dose, titration schedule, and personal factors
Treatment resulted in 12 kg weight loss, reduced body/visceral fat, improved glycemic variability, lower GMI with stable TIR, and modest insulin dose reduction